Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats

BACKGROUND: Recently, cinacalcet (CINA) has been shown to be effective for attenuating bone loss in the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), which might be associated with the reduction in serum parathyroid hormone (PTH) levels. However, th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Transl Med
Main Authors: Ni, Li-Hua, Tang, Ri-Ning, Yuan, Cheng, Song, Kai-Yun, Wang, Li-Ting, Zhang, Xiao-Liang, Lv, Lin-Li, Wang, Bin, Wu, Min, Tang, Tao-Tao, Li, Zuo-Lin, Yin, Di, Cao, Jing-Yuan, Wang, Xiao-Chen, Liu, Hong, Chen, Qiang, Liu, Bi-Cheng
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694248/
https://ncbi.nlm.nih.gov/pubmed/31475182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.06.44
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki